BIO 2024 New Pain Therapeutics: Strategies for Innovation, Investment, and Collaboration

Join Outcome Capital’s Dr. Paul Mieyal at Bio 2024 in San Diego on June at 11:00 AM, where he will be a panelist for the New Pain Therapeutics: Strategies for Innovation, Investment, and Collaboration session. This session addresses the opioid crisis head-on by exploring how the NIH, small biotech, biopharma, and VCs can rejuvenate CNS & pain innovation. The session will focus on pioneering strategies, boosting investment, and fostering public-private partnerships to fuel next-gen pain therapeutics and address this critical health need.